SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-058969
Filing Date
2016-03-24
Accepted
2016-03-24 17:18:40
Documents
1
Period of Report
2016-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 12733
  Complete submission text file 0001140361-16-058969.txt   15249
Mailing Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116
Business Address 6172108300
KLARMAN SETH A (Reporting) CIK: 0000899869 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 161527991

Mailing Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVENUE STE 1700 BOSTON MA 02116 6172108300
SAK CORP (Reporting) CIK: 0001061088 (see all company filings)

State of Incorp.: MA
Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 161527992

Mailing Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116
Business Address 10 ST JAMES AVE SUITE 1700 BOSTON MA 02116 617-210-8300
BAUPOST GROUP LLC/MA (Reporting) CIK: 0001061768 (see all company filings)

State of Incorp.: MA
Type: 3 | Act: 34 | File No.: 001-33415 | Film No.: 161527993

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations